Login / Signup

Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.

Patricia Volkow-FernándezLeslie Chavez GalanLucero Ramon-LuingJudith Cruz-VelazquezPatricia Cornejo-JuarezIsabel Sada-OvalleRogelio Perez-PadillaBeda Islas-Muñoznull null
Published in: PloS one (2023)
Although mortality attributable to KS was lower in the EG the difference was not statistically significant.
Keyphrases
  • randomized controlled trial
  • cardiovascular events
  • risk factors
  • study protocol
  • cardiovascular disease
  • early onset
  • type diabetes
  • systematic review
  • stem cells